Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-6-22
pubmed:abstractText
The purpose of this study was to analyze the radiotherapy (RT) quality assurance (QA) assessment in Japan Clinical Oncology Group (JCOG) 0202, which was the first trial that required on-going RT QA review in the JCOG.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-10869742, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-12382774, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-15845568, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-16170482, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-1647185, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-17047260, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-18234433, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-2674086, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-6286086, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-6286087, http://linkedlifedata.com/resource/pubmed/commentcorrection/19490617-8172436
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1748-717X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
16
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202.
pubmed:affiliation
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan. nao5-tky@umin.ac.jp
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III, Research Support, N.I.H., Extramural